Published in Cancer Res on April 15, 1997
Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods. J Virol (2003) 2.10
Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J Virol (1999) 1.59
A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors. Mol Ther (2009) 1.50
Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J Virol (2000) 1.37
Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther (2006) 1.34
Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells. J Virol (2000) 1.33
Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber. J Virol (1999) 1.28
Strategies to overcome host immunity to adenovirus vectors in vaccine development. Expert Rev Vaccines (2009) 1.08
Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter. J Virol (2001) 1.05
Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells. J Virol (2001) 0.99
Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. J Virol (2002) 0.92
Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines. J Virol (2002) 0.92
Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens. Proc Natl Acad Sci U S A (1999) 0.91
In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene. Mol Imaging Biol (2007) 0.91
Chapter two--Adenovirus strategies for tissue-specific targeting. Adv Cancer Res (2012) 0.90
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications. Neoplasia (1999) 0.88
Retargeting of viruses to generate oncolytic agents. Adv Virol (2011) 0.84
Retargeting adenoviral vectors to improve gene transfer into tumors. Cancer Gene Ther (2010) 0.81
Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody. J Mol Biol (2009) 0.80
Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer. Br J Cancer (2010) 0.79
The promise and potential hazards of adenovirus gene therapy. Gut (2001) 0.78
Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol (1995) 15.19
Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci U S A (1985) 4.60
Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 4.41
Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) (1982) 4.08
Identification of a ligand for the c-kit proto-oncogene. Cell (1990) 4.04
Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell (1990) 3.98
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med (2001) 3.81
Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A (1986) 3.42
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol (1998) 3.32
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc Natl Acad Sci U S A (2000) 3.10
Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res (1981) 3.00
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene (1990) 2.97
Retrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissues. J Clin Microbiol (1999) 2.89
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol (1996) 2.52
Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 2.46
Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J (1997) 2.43
Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1. Science (1990) 2.40
Role of basic fibroblast growth factor in vascular lesion formation. Circ Res (1991) 2.38
Blood clearance rates of adenovirus type 5 in mice. J Gen Virol (2000) 2.36
Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun (1985) 2.33
A dual receptor system is required for basic fibroblast growth factor activity. Cell (1991) 2.27
Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med (1989) 2.22
Porins of Brucella species. Infect Immun (1984) 2.17
Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol (1996) 2.14
Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci U S A (1998) 2.11
Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun (1987) 2.08
Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol (1990) 2.07
Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer. J Nucl Med (1997) 2.05
Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun (1986) 1.97
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther (2001) 1.92
Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest (1983) 1.91
High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci U S A (1992) 1.90
Replicative adenoviruses for cancer therapy. Nat Biotechnol (2000) 1.89
Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol (1998) 1.88
Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat Biotechnol (2001) 1.83
Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc Natl Acad Sci U S A (1986) 1.82
Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum Gene Ther (1998) 1.77
Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci U S A (1992) 1.72
Application of a polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues. J Clin Microbiol (1991) 1.70
Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol (1997) 1.66
Characterization of infectivity of knob-modified adenoviral vectors in glioma. Cancer Biol Ther (2008) 1.61
Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res (1998) 1.59
Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells. Nat Biotechnol (1998) 1.59
Effects of injected Alzheimer beta-amyloid cores in rat brain. Proc Natl Acad Sci U S A (1991) 1.58
Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol (1988) 1.56
Social phobia in adults with stuttering. Am J Psychiatry (1996) 1.55
Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation? Eur Heart J (2013) 1.55
Gene expression in chemically transformed mouse embryo cells: selective enhancement of the expression of C type RNA tumor virus genes. Cell (1977) 1.52
Histopathological survey of aborted bovine fetuses in Scotland with special reference to Neospora caninum. Vet Rec (2000) 1.52
The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest (1989) 1.51
Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice. Infect Immun (1989) 1.49
Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody. Gynecol Oncol (1995) 1.47
bFGF is the putative natural growth factor for human melanocytes. In Vitro Cell Dev Biol (1987) 1.46
A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. Clin Cancer Res (2001) 1.43
Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J Virol (2001) 1.43
Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther (1995) 1.42
Multiple influences of a heparin-binding growth factor on neuronal development. J Cell Biol (1987) 1.40
A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat Biotechnol (1999) 1.39
Adenoviral vector infection of the human exocrine pancreas. Arch Surg (1997) 1.38
Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. J Pediatr Hematol Oncol (2001) 1.37
Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther (2001) 1.36
Toxicological interactions among arsenic, cadmium, chromium, and lead in human keratinocytes. Toxicol Sci (2001) 1.35
Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog Horm Res (1986) 1.35
Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J Neurochem (2001) 1.35
bFGF as an autocrine growth factor for human melanomas. Oncogene Res (1988) 1.35
Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther (2006) 1.34
Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol (1983) 1.34
Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells. J Virol (2000) 1.33
In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis (1995) 1.32
Basic fibroblast growth factor (FGF) in the central nervous system: identification of specific loci of basic FGF expression in the rat brain. Growth Factors (1989) 1.32
Magic angle spinning NMR of the protonated retinylidene Schiff base nitrogen in rhodopsin: expression of 15N-lysine- and 13C-glycine-labeled opsin in a stable cell line. Proc Natl Acad Sci U S A (1999) 1.32
Primary structure of bovine brain acidic fibroblast growth factor (FGF). Biochem Biophys Res Commun (1985) 1.31
A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury. J Neurosci (1992) 1.30
A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res (1995) 1.30
Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res (1995) 1.30
The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer (2002) 1.29
1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev (1997) 1.29
Has the rising incidence of Crohn's disease reached a plateau? Br Med J (Clin Res Ed) (1982) 1.29
Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors (1991) 1.29
Induction and reversion of the L-form of Neisseria gonorrhoeae. Can J Microbiol (1973) 1.28
Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors. Biochemistry (1985) 1.28
Human brain fibroblast growth factor. Isolation and partial chemical characterization. FEBS Lett (1985) 1.27
Immunohistochemistry in the evaluation of neovascularization in tumor xenografts. Biotech Histochem (2008) 1.27
Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J Immunol (1999) 1.26
Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg (1999) 1.25
Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem Biophys Res Commun (1988) 1.25
Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome. Skeletal Radiol (1999) 1.25
Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice. Clin Exp Metastasis (2007) 1.24
Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology (1985) 1.23
Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am J Pathol (1992) 1.23
Fibroblast growth factors. Br Med Bull (1989) 1.23